Press coverage about Dextera Surgical (NASDAQ:DXTR) has trended positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Dextera Surgical earned a coverage optimism score of 0.37 on Accern’s scale. Accern also assigned press coverage about the medical instruments supplier an impact score of 44.4751779604324 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Separately, Zacks Investment Research raised shares of Dextera Surgical from a “sell” rating to a “hold” rating in a report on Tuesday, December 12th.
Shares of Dextera Surgical (DXTR) opened at $0.03 on Monday. Dextera Surgical has a 1-year low of $0.03 and a 1-year high of $1.98. The company has a market cap of $2.78, a price-to-earnings ratio of -0.02 and a beta of -1.92.
Dextera Surgical (NASDAQ:DXTR) last posted its earnings results on Thursday, November 9th. The medical instruments supplier reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.02). The firm had revenue of $0.69 million for the quarter, compared to analyst estimates of $0.62 million. analysts predict that Dextera Surgical will post -0.27 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This report was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/12/dextera-surgical-dxtr-earns-news-impact-rating-of-0-37.html.
Dextera Surgical Company Profile
Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.
Receive News & Ratings for Dextera Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical and related companies with MarketBeat.com's FREE daily email newsletter.